Delivery Order SPE2DB22D1202-SPE2DB25FVLM0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe form, valued at $1,246.38 under a firm fixed price contract type. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 12, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA 19428. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format, valued at $2,903.88 with a firm fixed price structure. Issued on August 14, 2025, with an ultimate completion date of August 15, 2025, this competitively awarded contract contains no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format, valued at $1,455.70 with a completion date of September 10, 2025. This contract is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a competitive procurement through open competition, consistent with AmerisourceBergen's established track record as a primary pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe form, valued at $1,569.21, with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $2,162.19 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competitive delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a firm fixed-price transaction under AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format, valued at $4,351.64 with a firm fixed price structure. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine procurement of immunization products to...
- The Defense Logistics Agency awarded a delivery order valued at $1,455.72 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. Issued on April 25, 2025, with a completion date of April 28, 2025, this firm fixed-price contract represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting...
- The Defense Logistics Agency awarded a $11,068.93 delivery order to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe form, with an ultimate completion date of September 17, 2025. This contract represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters and primary distribution hub. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $108,249.16 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, reflecting AmerisourceBergen's demonstrated capability to compete successfully...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLM0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format, valued at $19,778.01 under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and has an ultimate completion date of September 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which represents one of numerous pharmaceutical and medical supply transactions the company fulfills through its federal contracting relationships. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and medical devices to support military healthcare programs globally. AmerisourceBergen's substantial federal contract portfolio demonstrates its established capability as a critical vendor within the Defense Health Agency's pharmaceutical supply chain and underscores its role in supporting medical readiness for the Department of Defense and affiliated healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 9/16/25 |